Johns Hopkins-led consortium gets $200 million to fight top global health threat: tuberculosis

Johns Hopkins Medicine has received $200 million in federal funding to head up a consortium aimed at treating and stemming the spread of one of the world’s oldest and deadliest scourges: tuberculosis. The money from the U.S. Agency for International Development, to be spent over the next five years, will boost research into diagnostics, treatments, transmission control and prevention of TB, a bacterial infection that normally infects the lungs.